Andre Nussenzweig, Ph.D., has been elected to membership in EMBO, the European Molecular Biology Organization.
Karlyne Reilly, Ph.D., was awarded a Neurofibromatosis Therapeutic Acceleration Program (NTAP) grant to support her work for "Development of a Novel Plexiform Neurofibroma Farming System for 96-well Plate Drug Screening."
Brigitte Widemann, M.D., was awarded a NTAP grant to support a natural history study and longitudinal assessment of children, adolescent, and adults with neurofibromatosis type 1 (NF1).
Kent Hunter, Ph.D., was awarded a DoD grant for his project titled "Identifying metastasis susceptibility genes for estrogen receptor negative breast cancer."
Joseph Kim, M.D., was awarded a Young Investigator Award by the Conquer Cancer Foundation of ASCO to support his study entitled "Evaluating the impact of enzalutamide on production of nave T cells and its implication for vaccine combination."
Terry van Dyke, Ph.D., has received a grant from the Lustgarten Foundation to support studies entitled "In vivo analysis of a Vitamin D-receptor Agonist as a cancer therapy modulator in a Kras/p53 Dependent Murine Model of PDAC."
Xia Ding, Ph.D., has been awarded a DoD grant for his project titled "A genome-wide siRNA screen to identify BRCA2 genetic interactors that contribute to breast tumorigenesis and resistance to PARP inhibitors."
NIH Director's Awards
The following CCR staff members have been selected to receive a 2013 NIH Directors Award for their outstanding work on trans-NIH activities.
Janelle Cortner, Ph.D., Xin Wang, Ph.D. - Group award to recognize the extraordinary efforts of individuals from multiple NIH Institutes, Centers and Offices in creating an innovative program to foster US-China biomedical research cooperation
Edward Cowen, M.D., MHSC - For sustained achievement in bringing the treatment of NOMID with IL-1 blockade from conception to FDA approval
Crystal Mackall, M.D. - for fundamental advances in human T-cell homeostasis, and innovative approaches to improving bone marrow transplantation, HIV therapy, adoptive cell therapy for cancer, and other treatments
Deborah Morrison, Ph.D. - for major breakthroughs in elucidating the mechanisms of Ras/Raf signaling that will be critical for diagnosis and treatment of disease
Leonard Neckers, Ph.D. - for extraordinary contributions to cancer research, including identification and validation of Hsp90 as an anticancer molecular target and identification of the first-in-class clinical Hsp90 inhibitor
Peter Pinto, M.D. - The Alan S. Rabson Award for Clinical Care for scientific and medical excellence and the outstanding, compassionate care for patients and those who love them
Jeff Shilling - for outstanding leadership and vision in creating the NIH Intramural Research Program (IRP) Web site and for advancing allied efforts to raise the public profile of the IRP
Louis Staudt, M.D., Ph.D. - in recognition of the creation of a platform allowing the first large-scale testing of combinations of drugs, enabling NIH to efficiently search for next-generation therapeutics
2013 NIH Postbac Poster Awards for Outstanding Posters
The following CCR trainees were recognized for having authored posters that scored in the top 20 percent of all posters presented: Krist Aploks, Ashley S. Denney, Andrew Huehn, Youseung Kim, Paola Lopomo, Owen Smith, Yorleny M. Vicioso, and Matthew Weiss.
A service of the National Cancer Institute
